Life Sciences

After selling its hemophilia drug program to an Illinois company earlier this year, French pharmaceutical company Ipsen has announced it will relocate its U.S. research and development activities to Cambridge in 2014.

Life sciences manufacturer SeraCare Life sciences of Milford said it has expanded its research and development facilities at its headquarters, driven by new manufacturing opportunities it's undertaking with partners, the company said.

PLC Systems of Milford raised $1.75 million through the sale of or purchase warrants for more than 58 million shares.

Just as Boston Scientific wrapped up a years-long fight over stent patents, the Natick-based medical device manufacturer was hit with another suit by the family of the inventor of the pacemaker, alleging a secret deal.

Cambridge-based Genzyme, which has facilities in Northborough and Framingham, has announced the European approval of its second multiple sclerosis drug in less than a month.

A medical device made by Boston Scientific of Natick that's used to treat severe forms of asthma has been shown to be safe and effective, according to data published online in a medical journal.

Marlborough-based drug manufacturer Acton Pharmaceuticals is being acquired by a Swedish company in an all-cash transaction that could approach $200 million.

Researchers at Worcester Polytechnic Institute working on therapies to heal cardiac muscle damage have received a grant from the National Institutes of Health (NIH), the school announced today.

Milford-based Waters Corp. announced its CEO will step down and a transition plan is being put into place.

A veteran executive of the life sciences industry has been named to the top position at Harvard Bioscience of Holliston.